医学
重症监护医学
抗生素
肝衰竭
并发症
抗生素耐药性
抗生素治疗
内科学
微生物学
生物
作者
Simone Incicco,Paolo Angeli,Salvatore Piano
标识
DOI:10.1016/j.cld.2023.03.013
摘要
Bacterial infections (BIs) are the most common precipitating event of acute-on-chronic liver failure (ACLF) and a frequent complication of ACLF. BIs aggravate the course of the syndrome and are associated with higher mortality rates. For this reason, BIs should be promptly diagnosed and treated in all patients with ACLF. The administration of an appropriate empirical antibiotic therapy improves survival in patients with BIs and ACLF and is the cornerstone of treatment. Due to the spread of antibiotic resistance worldwide, the empirical treatment should cover multi-drug-resistant organisms. Herein we reviewed the current evidence about the management of BIs in ACLF.
科研通智能强力驱动
Strongly Powered by AbleSci AI